Who
Charles Dadswell
EVP, General Counsel
Company insider
Files Form 4 as: EVP, General Counsel, Masimo; SVP, General Counsel, Illumina.
In numbers
- Trades disclosed
- 163
- Buys
- 0
- Sells
- 76
- Bought
- $0
- Sold
- $12.2M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 29 Jan 2014
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —11,886 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —10,261 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —11,886 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —10,261 | filing |
| 6 Mar 2026filed 10 Mar 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code A | —10,261 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | Masimooption or derivative | SEC FORM 4 Code A | —10,261 at $0.00 | filing |
| 13 Sep 2024filed 17 Sep 2024 | ILMN IlluminaLife-science tools | SEC FORM 4 Code D | $126K989 at $126.95 | filing |
| 15 Aug 2024filed 19 Aug 2024 | ILMN IlluminaLife-science tools | SEC FORM 4 Code D | $122K989 at $123.56 | filing |
| 5 Mar 2024filed 7 Mar 2024 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,797 at $0.00 | filing |
| 5 Mar 2024filed 7 Mar 2024 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,797 at $0.00 | filing |
| 5 Mar 2024filed 7 Mar 2024 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —6,683 at $0.00 | filing |
| 5 Nov 2023filed 7 Nov 2023 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $172K1,523 at $112.84 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,771 at $0.00 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,156 at $0.00 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —6,926 at $0.00 | filing |
| 21 Feb 2023filed 23 Feb 2023 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,282 at $0.00 | filing |
| 21 Feb 2023filed 23 Feb 2023 | ILMN IlluminaLife-science tools | SEC FORM 4 Code M | —5,282 at $0.00 | filing |
| 21 Feb 2023filed 23 Feb 2023 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $387K1,907 at $202.84 | filing |
| 5 Nov 2022filed 8 Nov 2022 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $185K853 at $217.19 | filing |
| 28 Apr 2022filed 2 May 2022 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $110K368 at $300.13 | filing |
News
Illumina To Webcast Upcoming Investor ConferenceILMN · prnewswire.com · 20 Oct 2026Illumina's (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself?ILMN · insidermonkey.com · 13 Oct 2026
0 headlines in the last 90 days name Charles Dadswell; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.